Venous obstruction. A potential complication of transvenous pacemaker electrodes. 1983

T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson

Pervenous endocardial pacing using a self-contained, totally implantable system was popularized in this country by Chardack in 1965 and subsequently has become the established mode of permanent pacing. Although this intervention may be lifesaving, it is not without risk. Occlusion of major vessels incited by the presence of a pacing electrode is an extremely rare occurrence. We describe four patients who had occlusion of the axillary or subclavian veins or of the superior vena cava due to pervenous pacing electrodes. We review the literature of previous observation of venous occlusion and thromboembolic complications due to pervenous pacemakers, describe the clinical features accompanying venous obstruction, and review pathophysiology and proposals for treatment. The use of noninvasive radionuclide venography serves as a useful adjunct in the diagnosis of venous obstruction from pacing catheters.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010138 Pacemaker, Artificial A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external). Cardiac Pacemaker, Artificial,Artificial Cardiac Pacemaker,Artificial Cardiac Pacemakers,Artificial Pacemaker,Artificial Pacemakers,Cardiac Pacemakers, Artificial,Pacemaker, Artificial Cardiac,Pacemakers, Artificial,Pacemakers, Artificial Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001367 Axillary Vein The venous trunk of the upper limb; a continuation of the basilar and brachial veins running from the lower border of the teres major muscle to the outer border of the first rib where it becomes the subclavian vein. Axillary Veins,Vein, Axillary,Veins, Axillary
D013350 Subclavian Vein The continuation of the axillary vein which follows the subclavian artery and then joins the internal jugular vein to form the brachiocephalic vein. Subclavian Veins,Vein, Subclavian,Veins, Subclavian
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
August 1980, British heart journal,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
June 1974, American heart journal,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
March 1990, Pacing and clinical electrophysiology : PACE,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
February 1983, Chest,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
November 1988, Japanese circulation journal,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
December 1968, The American journal of nursing,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
November 1979, American heart journal,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
January 2011, Medicina intensiva,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
January 2019, Indian heart journal,
T Fritz, and J F Richeson, and P Fitzpatrick, and G Wilson
March 1992, Mayo Clinic proceedings,
Copied contents to your clipboard!